ストックスクリーナーアプリを入手
0.52
4.15%
-0.0225
プレマーケット:
.52
Evogene Ltd (EVGN) 最新ニュース
Evogene Ltd (EVGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Form 13D/A Evogene Ltd. For: 27 July By Investing.com - Investing.com South Africa
Evogene Ltd (EVGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Evogene Ltd (EVGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Evogene Ltd. (EVGN) holders report 17.41% stake and new ADS buys - Stock Titan
Evogene Ltd (EVGN) Balance Sheet - TradingKey
EVGN|Evogene Ltd|Price:0.542|Chg%:-0.006 - TradingKey
Evogene Ltd (EVGN) Cash Flow - TradingKey
AI is rewiring future of energy cropsOfer Haviv, CEO, Evogene (EVGN) - AgroSpectrum India
EVGN|Evogene Ltd|Price:0.518|Chg%:-0.024 - TradingKey
Evogene and ELEO join forces to develop next-gen oral PCSK9 drugs targeting billion-dollar cardio market - Indian Pharma Post
Evogene Ltd (EVGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Evogene Ltd (EVGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Evogene Ltd. (EVGN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Evogene Ltd (EVGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Evogene and ELEO to develop new oral PCSK9 inhibitors - Pharmaceutical Business review -
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Evogene and Eleo collaborate to discover PCSK9 pathway inhibitors - BioWorld News
Evogene (EVGN) Q1 2026 Earnings: Wider-than-Expected Loss Amid Ongoing R&D InvestmentsEarnings Analysis - dars.gov.et
Evogene and ELEO partner on oral PCSK9 inhibitor development By Investing.com - Investing.com South Africa
Evogene & ELEO Partner on Oral PCSK9 Inhibitors - AllSci
Evogene, ELEO Collaborating to Develop Oral PCSK9 Inhibitors - Moomoo
Evogene and ELEO partner on oral PCSK9 inhibitor development - Investing.com
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases - PR Newswire
Evogene stock trades quietly as genomics group leans on cash and recent revenue growth - Ad-hoc-news.de
Evogene (EVGN) investors add 202K ADSs, now hold 16.81% stake - Stock Titan
Evogene Expands ATM Offering as Shareholder Activism Escalates - TipRanks
EVGN (Nasdaq: EVGN) raises at-the-market ordinary share offering to $3.29M - Stock Titan
Activist investors target Evogene (NASDAQ: EVGN) board as ATM capacity rises - Stock Titan
AgPlenus Launches Antifungal Potency Predictor, Expanding ChemPass AI for Ag Capabilities - iGrow News
AgPlenus launches AI model to predict antifungal potency By Investing.com - Investing.com Nigeria
AgPlenus launches AI model to predict antifungal potency - Investing.com
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities - Nasdaq
Evogene (EVGN) Edges Higher: Testing Key Resistance Amid Volume ShiftDefined Outcome ETF - dars.gov.et
EVGN Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Pre-Revenue Biotech Advances PlatformSpecial Dividend Alert - Bölüm Sonu Canavarı
Kfir Silberman Pushes for Board Changes at Evogene with 12.61% Stake - TradingView
Evogene (EVGN) investors with 12.61% and 4.13% stakes seek major board changes - Stock Titan
Evogene and Tel Aviv University launch drug discovery initiative - Pharmaceutical Business review -
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery - Global Agriculture
Evogene and Tel Aviv University team up to speed small-molecule drug discovery - Stock Titan
Evogene Ltd. and Blavatnik Center For Drug Discovery at Tel Aviv University Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery - marketscreener.com
Evogene Partners with Tel Aviv University on AI Drug... - AllSci
Evogene and Tel Aviv University to accelerate AI-driven small-molecule drug discovery - BioSpectrum Asia
Evogene partners with Tel Aviv University center on drug discovery - Investing.com
Evogene partners with Tel Aviv University center on drug discovery By Investing.com - Investing.com India
Evogene Ltd (EVGN) Edges Higher Amid Consolidation, Testing Key Resistance at $0.46Double EMA - dars.gov.et
How Evogene is changing the future for the pharma and agriculture markets - The Jerusalem Post
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):